Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel disease.

Shah SB, Hanauer SB. Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel disease. Rev Gastroenterol Disord. 2008; 8(3):159-68.

View in: PubMed

collapse authors with profiles